Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. Consider and adopt the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has informed stock exchanges that its Board of Directors will meet on Friday, May 30, 2025 at 4:00 PM. The main agenda is to consider and approve the Audited Financial Results (both Standalone and Consolidated) for the quarter and full year ended March 31, 2025. The Board will also review the Independent Reports of the Statutory Auditor on these financial statements. As per insider trading rules, the trading window for designated persons remains closed and will reopen 48 hours after the results are declared.
This is a routine pre-results announcement. Investors should watch the May 30 outcome closely as the audited FY25 numbers and any dividend/related disclosures announced during the meeting could move the stock.